Transcranial magnetic stimulation, usually called TMS, is a medical treatment that uses magnetic pulses delivered through a coil placed against the scalp. Repetitive TMS, or rTMS, delivers repeated pulses to a selected brain region. The person remains awake, and treatment does not require surgery or general anaesthesia.
For depression, TMS may be considered when previous treatment has not helped sufficiently or has been difficult to tolerate. It is not a guaranteed cure or an interchangeable substitute for every other treatment. The device, protocol, diagnosis and clinical assessment all matter.
What is TMS treatment?
The National Institute of Mental Health describes rTMS as a non-invasive brain-stimulation treatment. The magnetic field induces electrical activity in targeted brain tissue without passing an electrical current through scalp electrodes in the way ECT does.
The intended effect is to influence networks involved in mood and other functions. Descriptions such as resetting the brain are oversimplifications: response varies, the mechanisms remain under investigation, and meaningful recovery involves more than a change during stimulation.
TMS is administered by a trained clinical team using medical equipment. A consumer device marketed for relaxation or focus should not be assumed to provide the same intervention.
When is rTMS considered for depression?
NICE guidance considers the evidence sufficient for rTMS to be used for depression with appropriate clinical arrangements, while emphasising that benefit differs between people.
A specialist should review the diagnosis, previous medication and therapy, current symptoms and treatment goals. The phrase treatment-resistant depression needs explanation: which treatments were tried, for how long, and why were they unsuccessful or stopped?
The depression treatment guide sets out the wider options. Severe deterioration, psychotic symptoms or immediate safety concerns may change the recommended setting and urgency of care rather than simply make someone a candidate for an outpatient TMS course.
Assessment and safety screening
Before treatment, explain your medical history, previous seizures or brain injury, implanted devices, operations and all medicines you take. Metal or electronic implants near the treatment area require particular assessment; the clinic should check compatibility rather than rely on a general assumption.
Tell the clinician about major sleep changes, alcohol or other substance use, and past episodes of unusually elevated mood. These details can influence risk assessment and the treatment plan.
Bring a current medication list and relevant records. Ask who provides medical oversight, how concerns between sessions are handled and what would lead the team to recommend a different approach.
What happens at the first appointment?
Oxford Health NHS information describes positioning the coil, taking measurements and, where appropriate, establishing a motor threshold. This helps clinicians individualise stimulation settings; it is not a test of intelligence or effort.
You sit in a treatment chair and wear hearing protection. The equipment makes clicking sounds, and the pulses can produce a tapping sensation or muscle twitching around the scalp.
Tell staff when a sensation is painful, frightening or difficult to tolerate. They can assess positioning and the treatment settings. You do not need to remain silent to demonstrate commitment to treatment.
What does a course involve?
Many conventional depression protocols involve weekday appointments over several weeks. Session length varies substantially by protocol, and preparation, checks and travel add to the time required.
Ask for the complete schedule before beginning. Someone balancing work, caring responsibilities or a long journey needs to know whether the commitment is manageable, not just that an individual stimulation sequence is brief.
Agree how missed appointments, illness and changes in medication will be managed. A realistic plan should explain review points and what happens when improvement is limited, rather than assume that completing a fixed package guarantees benefit.
Theta-burst, deep TMS and accelerated treatment
Intermittent theta-burst stimulation, or iTBS, is a particular pattern of magnetic stimulation. Deep TMS uses a different coil design. Accelerated programmes deliver multiple sessions within a shorter period. These terms describe meaningful differences, not simply stronger versions of one universal treatment.
In the THREE-D randomised trial, a three-minute iTBS protocol was non-inferior to a longer standard rTMS protocol for adults with treatment-resistant depression. That finding applies to the studied treatments and population; it does not validate every shortened or accelerated schedule.
Ask which protocol the service uses and which research supports it. A marketing label alone does not establish that a clinic is reproducing a particular published intervention.
What does the evidence show?
Clinical trials support rTMS as a treatment option for depression, but results depend on patient selection, protocol and how improvement is measured. Response, remission and sustained recovery describe different outcomes.
A small sham-controlled trial of Stanford neuromodulation therapy found greater improvement with an individually targeted accelerated protocol than with sham treatment. The researchers also identified the need for further work on durability and comparisons with other treatments.
It would be misleading to turn a result from a small specialist study into a guaranteed success rate for every TMS clinic. Ask how the service measures its own outcomes and whether reported results include people who stopped treatment early.
Side effects and uncommon risks
Oxford Health lists scalp twitching, headache and tiredness among possible effects. A seizure is an uncommon but important risk, and some people may experience hypomanic or manic symptoms.
Risk can be affected by factors such as sleep deprivation, alcohol, brain injury and medication changes. Inform the team about relevant changes before a session, rather than assume that passing the initial screening settles suitability for the whole course.
Hearing protection is part of appropriate treatment. New or persistent symptoms should be reported. Non-invasive does not mean risk-free, and an uncomfortable experience should not be dismissed as evidence that the treatment must be working.
How TMS differs from ECT
Electroconvulsive therapy deliberately produces a controlled seizure under general anaesthesia. Standard TMS does not intentionally induce a seizure and is performed while the person is awake.
The procedures also have different clinical roles and adverse-effect profiles. Choosing between them is not simply a matter of selecting the less intensive-looking option, particularly when severe illness requires urgent treatment.
Memory concerns should be discussed with either service, but ECT’s recognised risk of autobiographical memory loss should not be automatically attributed to TMS. Equally, concerns about concentration during treatment deserve assessment rather than a blanket assurance.
Medication and talking therapy during TMS
A TMS course can be part of a broader treatment plan. Pennine Care NHS information explains that antidepressants and talking therapies may continue during treatment, with changes discussed with the clinical team.
Do not stop medication independently because a non-drug intervention has begun. Coordinate with the prescriber through medication review, especially if new symptoms or adverse effects emerge.
Psychological therapy and practical support can address ongoing difficulties that stimulation alone may not resolve. The plan should reflect your circumstances rather than treat the machine as the entire service.
Reviewing progress and planning afterwards
Track changes in both symptoms and functioning. Being more able to prepare meals, maintain contact or return to meaningful activity can add context to a rating scale.
Agree when the team will review response and what the alternatives are if benefit is insufficient. Continuing indefinitely without reassessing the purpose is not the same as providing individualised care.
Some people are offered further or maintenance treatment, but arrangements vary. Ask how relapse will be recognised, who remains responsible for care and what future appointments or costs may be involved.
Practical questions before committing
Clarify the full price, including assessment, treatment, reviews and any proposed maintenance. Confirm whether the device and protocol are appropriate for the indication and location where care is delivered.
Ask about staff training, medical supervision, emergency procedures and how your experience will be recorded. A clear written explanation is more useful than an impressive device name without details.
Discuss transport and activity after sessions with the service. Although standard TMS does not involve anaesthesia, tiredness, illness and individual circumstances can still affect whether you are fit to drive or work safely.
Frequently asked questions about TMS
Does TMS hurt?
People commonly describe tapping, scalp discomfort or twitching. Some experience headache. Tell the team about pain so positioning, settings and suitability can be reviewed rather than trying to endure an intolerable session.
Will I be asleep during treatment?
No. Standard TMS is performed while you are awake and does not require general anaesthesia. You can communicate with staff during the appointment and raise concerns as they arise.
How many appointments will I need?
This depends on the protocol and response. Conventional courses often involve repeated weekday sessions over several weeks. Accelerated schedules differ and should be explained with their supporting evidence.
Can I stop antidepressants before starting?
Do not change medication independently. The prescriber and TMS team should agree any changes, because withdrawal, symptom recurrence and effects on treatment safety need consideration.
Does TMS work for everyone?
No. Some people improve substantially, some partially and others not enough to justify continuing. Ask how outcomes will be assessed and what the next option would be if treatment is unsuccessful.
Is a shorter protocol automatically better?
No. Convenience matters, but the evidence concerns defined protocols rather than speed alone. Ask how the proposed schedule compares with the research and what is known about sustained benefit.
Discussing your options
A clinical assessment can help clarify the appropriate level of care and compare treatment options. Contact VAYEMA to discuss your current difficulties and the next step.
Sources and further reading
- NIMH: Brain stimulation therapies
- NICE: rTMS for depression
- THREE-D randomised trial
- Stanford neuromodulation therapy trial
- Oxford Health: TMS appointments
- Oxford Health: Side effects
- Pennine Care: About TMS
Related conditions and concerns
These links explain the wider care context. They are not a recommendation that this approach is suitable for everyone with the condition. Use the condition treatment guide to understand alternatives and the role of clinical assessment.